These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles. Yook S; Lu Y; Jeong JJ; Cai Z; Tong L; Alwarda R; Pignol JP; Winnik MA; Reilly RM Biomacromolecules; 2016 Apr; 17(4):1292-302. PubMed ID: 26974228 [TBL] [Abstract][Full Text] [Related]
10. Fluorescent, Plasmonic, and Radiotherapeutic Properties of the Mendoza-Nava H; Ferro-Flores G; Ramírez FM; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Luna-Gutiérrez M; Isaac-Olivé K Mol Imaging; 2017 Jan; 16():1536012117704768. PubMed ID: 28654384 [TBL] [Abstract][Full Text] [Related]
11. Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@Au core-shell for targeted drug delivery application. Karamipour Sh; Sadjadi MS; Farhadyar N Spectrochim Acta A Mol Biomol Spectrosc; 2015 Sep; 148():146-55. PubMed ID: 25879984 [TBL] [Abstract][Full Text] [Related]
12. Lanthanide (Gd(3+) and Yb(3+)) functionalized gold nanoparticles for in vivo imaging and therapy. Ge X; Song ZM; Sun L; Yang YF; Shi L; Si R; Ren W; Qiu X; Wang H Biomaterials; 2016 Nov; 108():35-43. PubMed ID: 27619238 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytotoxic and tumor targeting capability of (177)Lu-DOTATATE-nanoparticles: a trailblazing strategy in peptide receptor radionuclide therapy. Arora G; Dubey P; Shukla J; Ghosh S; Bandopadhyaya G Ann Nucl Med; 2016 Jun; 30(5):334-45. PubMed ID: 26897009 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and in vitro evaluation of targeted gold nanoshelled poly(d,l-lactide-co-glycolide) nanoparticles carrying anti p53 antibody as a theranostic agent for ultrasound contrast imaging and photothermal therapy. Xu L; Wan C; Du J; Li H; Liu X; Yang H; Li F J Biomater Sci Polym Ed; 2017 Mar; 28(4):415-430. PubMed ID: 28044473 [TBL] [Abstract][Full Text] [Related]
15. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer. Deshayes E; Ladjohounlou R; Le Fur P; Pichard A; Lozza C; Boudousq V; Sevestre S; Jarlier M; Kashani R; Koch J; Sosabowski J; Foster J; Chouin N; Bruchertseifer F; Morgenstern A; Kotzki PO; Navarro-Teulon I; Pouget JP J Nucl Med; 2018 Aug; 59(8):1234-1242. PubMed ID: 29674421 [TBL] [Abstract][Full Text] [Related]
16. A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging. Satterlee AB; Yuan H; Huang L J Control Release; 2015 Nov; 217():170-82. PubMed ID: 26341695 [TBL] [Abstract][Full Text] [Related]
17. [ Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614 [TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Park JA; Kim HK; Kim JH; Jeong SW; Jung JC; Lee GH; Lee J; Chang Y; Kim TJ Bioorg Med Chem Lett; 2010 Apr; 20(7):2287-91. PubMed ID: 20188545 [TBL] [Abstract][Full Text] [Related]
19. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer. Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789 [TBL] [Abstract][Full Text] [Related]